SSTR2 and hepatocellular carcinoma: These pathways are known to contribute to tumor proliferation, immune evasion, angiogenesis, and metastatic potential in HCC [17,18], suggesting that SSTR2 may promote a more aggressive tumor phenotype through modulation of these signaling networks.